Publications by authors named "Ignacio Alberca"

Claim this Profile
I
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Jorge Labrador, Lucia López-Corral, Lourdes Vazquez, Fermin Sánchez-Guijo, Carmen Guerrero, Ignacio Alberca

Br J Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia.
Jose R Gonzalez-Porras, Fernando Escalante, Emilia Pardal, Magdalena Sierra, Luis J Garcia-Frade, Ignacio Alberca

Eur J Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
Silvia Navarro, Pilar Medina, Elena Bonet, Javier Corral, Vicenta Martínez-Sales, Ignacio Alberca

Arterioscler Thromb Vasc Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.
Jorge Labrador, Lucia Lopez-Anglada, Estefania Perez-Lopez, Francisco S Lozano, Lucia Lopez-Corral, Ignacio Alberca

Haematologica· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
Iris Cordoba, Carlota Pegenaute, Tomás José González-López, Carmen Chillon, Maria Eugenia Sarasquete, Ignacio Alberca

Eur J Haematol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.
Jose Antonio Pérez-Simón, Soraya Tabera, María Eugenia Sarasquete, María Díez-Campelo, Javier Canchado, Ignacio Alberca

Cytotherapy· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of immature platelet fraction in acute coronary syndrome.
Jose Ramon Gonzalez-Porras, Francisco Martin-Herrero, Tomas J Gonzalez-Lopez, Juan Olazabal, María Diez-Campelo, Ignacio Alberca

Thromb Haemost· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria.
Pilar M Hernández-Campo, Julia Almeida, María J Acevedo, María L Sánchez, Ignacio Alberca

Transfusion· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Antonia Miñano, Adriana Ordóñez, Francisco España, José Ramón González-Porras, Ramón Lecumberri, Ignacio Alberca

Haematologica· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homocysteine and outcome in young patients with acute coronary syndromes.
Francisco Martín-Herrero, Javier Martín-Moreiras, Pedro Pabón, Pedro L Sánchez, José Luis Moríñigo-Muñoz, Ignacio Alberca

Int J Cardiol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.
Javier Corral, David Hernandez-Espinosa, Jose Manual Soria, Rocio Gonzalez-Conejero, Adriana Ordonez, Ignacio Alberca

Blood· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent and polymeric antithrombin: clearance and potential thrombotic risk.
Javier Corral, José Rivera, José A Guerrero, Antonia Miñano, Ignacio Alberca

Exp Biol Med (Maywood)· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.
Javier Corral, Rocio González-Conejero, Jose Manuel Soria, Jose Ramón González-Porras, Elena Pérez-Ceballos, Ignacio Alberca

Blood· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
Ignacio Alberca, Ma Soledad Asuero, José L Bóveda, Nelly Carpio, Enric Contreras

Med Clin (Barc)· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients.
Ramón Montes, Estefanía Ruiz de Gaona, Miguel Angel Martínez-González, Ignacio Alberca, José Hermida

Br J Haematol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
José Ramón González-Porras, Ramón García-Sanz, Ignacio Alberca, María Luz López, Ana Balanzategui

Blood Coagul Fibrinolysis· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic study of the digoxin-acenocoumarol interaction in rabbits.
Ana Martin-Suarez, Drury Rudolph Atencio, Francisco González Lopez, María Santos, Aránzazu Zarzuelo, Ignacio Alberca

Biol Pharm Bull· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease.
Ramón Lecumberri, Izaskun Ceberio, Ramón Montes, María Luz López, Ignacio Alberca

Haematologica· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prothrombin A19911G and G20210A polymorphisms' role in thrombosis.
Elena Pérez-Ceballos, Javier Corral, Ignacio Alberca, Amparo Vayá, Pilar Llamas

Br J Haematol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population.
José Zarza, José Hermida, Ramón Montes, Ignacio Alberca, Maria Luz López

Blood· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol.
José Hermida, José Zarza, Ignacio Alberca, Ramón Montes, María Luz López

Blood· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis